A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT05565560 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05565560
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-25
- Primary completion
- 2025-11-20
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.